MyFinsight
Home
Blog
About
Contact
Depreciation and
amortization
$184.8M
(4.76%↑ Y/Y)
Consolidated net income
$173.3M
(29.52%↑ Y/Y)
Stock-based compensation
expense
$43.3M
(29.25%↑ Y/Y)
Deferred income taxes
$13.5M
(550.00%↑ Y/Y)
Cash provided by
operating activities
$241.9M
(8.04%↑ Y/Y)
Canceled cashflow
$173M
Increase in cash and cash
equivalents
$2.6M
(-89.72%↓ Y/Y)
Canceled cashflow
$239.3M
Current and long term
liabilities, excluding debt
-$98.4M
(-74.78%↓ Y/Y)
Accounts receivable, net
$58.3M
(6.00%↑ Y/Y)
Other assets, current
and long-term
$16.3M
(196.36%↑ Y/Y)
Net short-term
borrowings (payments)
$214.9M
Proceeds from exercise of
stock options and...
$10.4M
(-15.45%↓ Y/Y)
Cash used in
investing activities
-$120.4M
(-12.31%↓ Y/Y)
Cash used in
financing activities
-$117.7M
(-22.86%↓ Y/Y)
Effect of foreign
currency exchange rates...
-$1.2M
(-127.27%↓ Y/Y)
Canceled cashflow
$225.3M
Capital expenditures
$120.4M
(12.31%↑ Y/Y)
Treasury stock purchases
$260M
Dividends paid to equifax
shareholders
$67.1M
(38.35%↑ Y/Y)
Payment of taxes related
to settlement of...
$14.5M
(26.09%↑ Y/Y)
Payments on long-term
debt
$1.4M
Back
Back
Cash Flow
equifax_150_28-svg
EQUIFAX INC (EFX)
equifax_150_28-svg
EQUIFAX INC (EFX)
source: myfinsight.com